141 related articles for article (PubMed ID: 32941911)
1. Generation and testing of engineered multimeric Fabs of trastuzumab.
Selis F; Sandomenico A; Cantile M; Sanna R; Calvanese L; Falcigno L; Dell'Omo P; Esperti A; De Falco S; Focà A; Caporale A; Iaccarino E; Truppo E; Scaramuzza S; Tonon G; Ruvo M
Int J Biol Macromol; 2020 Dec; 164():4516-4531. PubMed ID: 32941911
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Disulfide Bond Rebridged Fab-Drug Conjugates Prepared Using a Dual Maleimide Pyrrolobenzodiazepine Cytotoxic Payload.
Ruddle BT; Fleming R; Wu H; Gao C; Dimasi N
ChemMedChem; 2019 Jun; 14(12):1185-1195. PubMed ID: 30980702
[TBL] [Abstract][Full Text] [Related]
3. Comparative binding of disulfide-bridged PEG-Fabs.
Khalili H; Godwin A; Choi JW; Lever R; Brocchini S
Bioconjug Chem; 2012 Nov; 23(11):2262-77. PubMed ID: 22994419
[TBL] [Abstract][Full Text] [Related]
4. Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro.
Aubrey N; Allard-Vannier E; Martin C; Bryden F; Letast S; Colas C; Lakhrif Z; Collinet N; Dimier-Poisson I; Chourpa I; Viaud-Massuard MC; Joubert N
Bioconjug Chem; 2018 Nov; 29(11):3516-3521. PubMed ID: 30352511
[TBL] [Abstract][Full Text] [Related]
5. Site-specific coupling and sterically controlled formation of multimeric antibody fab fragments with unnatural amino acids.
Hutchins BM; Kazane SA; Staflin K; Forsyth JS; Felding-Habermann B; Schultz PG; Smider VV
J Mol Biol; 2011 Mar; 406(4):595-603. PubMed ID: 21237172
[TBL] [Abstract][Full Text] [Related]
6. An antibody with Fab-constant domains exchanged for a pair of CH3 domains.
Wozniak-Knopp G; Stadlmayr G; Perthold JW; Stadlbauer K; Gotsmy M; Becker S; Rüker F
PLoS One; 2018; 13(4):e0195442. PubMed ID: 29630643
[TBL] [Abstract][Full Text] [Related]
7. Efficient Site-Specific Antibody-Drug Conjugation by Engineering a Nature-Derived Recognition Tag for Microbial Transglutaminase.
Ebenig A; Juettner NE; Deweid L; Avrutina O; Fuchsbauer HL; Kolmar H
Chembiochem; 2019 Sep; 20(18):2411-2419. PubMed ID: 31044494
[TBL] [Abstract][Full Text] [Related]
8. Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies.
Donaldson JM; Zer C; Avery KN; Bzymek KP; Horne DA; Williams JC
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17456-61. PubMed ID: 24101516
[TBL] [Abstract][Full Text] [Related]
9. Small-animal SPECT/CT of HER2 and HER3 expression in tumor xenografts in athymic mice using trastuzumab Fab-heregulin bispecific radioimmunoconjugates.
Razumienko EJ; Scollard DA; Reilly RM
J Nucl Med; 2012 Dec; 53(12):1943-50. PubMed ID: 23096164
[TBL] [Abstract][Full Text] [Related]
10. Generation and Biological Evaluation of Fc Antigen Binding Fragment-Drug Conjugates as a Novel Antibody-Based Format for Targeted Drug Delivery.
Jäger S; Wagner TR; Rasche N; Kolmar H; Hecht S; Schröter C
Bioconjug Chem; 2021 Aug; 32(8):1699-1710. PubMed ID: 34185508
[TBL] [Abstract][Full Text] [Related]
11. MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using ¹¹¹In-labeled bispecific radioimmunoconjugates.
Razumienko E; Dryden L; Scollard D; Reilly RM
Breast Cancer Res Treat; 2013 Apr; 138(3):709-18. PubMed ID: 23525982
[TBL] [Abstract][Full Text] [Related]
12. Metal-Chelating Polymers (MCPs) with Zwitterionic Pendant Groups Complexed to Trastuzumab Exhibit Decreased Liver Accumulation Compared to Polyanionic MCP Immunoconjugates.
Liu P; Boyle AJ; Lu Y; Adams J; Chi Y; Reilly RM; Winnik MA
Biomacromolecules; 2015 Nov; 16(11):3613-23. PubMed ID: 26469142
[TBL] [Abstract][Full Text] [Related]
13. Redirecting adenoviruses to tumour cells using therapeutic antibodies: Generation of a versatile human bispecific adaptor.
Vasiljevic S; Beale EV; Bonomelli C; Easthope IS; Pritchard LK; Seabright GE; Caputo AT; Scanlan CN; Dalziel M; Crispin M
Mol Immunol; 2015 Dec; 68(2 Pt A):234-43. PubMed ID: 26391350
[TBL] [Abstract][Full Text] [Related]
14. Highly Potent, Anthracycline-based Antibody-Drug Conjugates Generated by Enzymatic, Site-specific Conjugation.
Stefan N; Gébleux R; Waldmeier L; Hell T; Escher M; Wolter FI; Grawunder U; Beerli RR
Mol Cancer Ther; 2017 May; 16(5):879-892. PubMed ID: 28258164
[TBL] [Abstract][Full Text] [Related]
15. An expanded genetic code facilitates antibody chemical conjugation involving the lambda light chain.
Kato A; Ohtake K; Tanaka Y; Yokoyama S; Sakamoto K; Shiraishi Y
Biochem Biophys Res Commun; 2021 Mar; 546():35-39. PubMed ID: 33561746
[TBL] [Abstract][Full Text] [Related]
16. Biotinylated polyacrylamide-based metal-chelating polymers and their influence on antigen recognition following conjugation to a trastuzumab Fab fragment.
Liu P; Boyle AJ; Lu Y; Reilly RM; Winnik MA
Biomacromolecules; 2012 Sep; 13(9):2831-42. PubMed ID: 22871127
[TBL] [Abstract][Full Text] [Related]
17. Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody-Drug Conjugates.
Kasper MA; Stengl A; Ochtrop P; Gerlach M; Stoschek T; Schumacher D; Helma J; Penkert M; Krause E; Leonhardt H; Hackenberger CPR
Angew Chem Int Ed Engl; 2019 Aug; 58(34):11631-11636. PubMed ID: 31250955
[TBL] [Abstract][Full Text] [Related]
18. Identification of highly reactive cysteine residues at less exposed positions in the Fab constant region for site-specific conjugation.
Shiraishi Y; Muramoto T; Nagatomo K; Shinmi D; Honma E; Masuda K; Yamasaki M
Bioconjug Chem; 2015 Jun; 26(6):1032-40. PubMed ID: 25978737
[TBL] [Abstract][Full Text] [Related]
19. Bacterial production and structure-functional validation of a recombinant antigen-binding fragment (Fab) of an anti-cancer therapeutic antibody targeting epidermal growth factor receptor.
Kim JH; Sim DW; Park D; Jung TG; Lee S; Oh T; Ha JR; Seok SH; Seo MD; Kang HC; Kim YP; Won HS
Appl Microbiol Biotechnol; 2016 Dec; 100(24):10521-10529. PubMed ID: 27470143
[TBL] [Abstract][Full Text] [Related]
20. Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target Antigen.
Selis F; Focà G; Sandomenico A; Marra C; Di Mauro C; Saccani Jotti G; Scaramuzza S; Politano A; Sanna R; Ruvo M; Tonon G
Int J Mol Sci; 2016 Apr; 17(4):491. PubMed ID: 27043557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
